Haote Han, Ling Zou, Jiaru Fang, Xiaobao Xu, Dongxin Xu, Xuelian Lyu, Jilin Zheng and Ning Hu*,
{"title":"基于心肌细胞的多模态生物传感平台用于生物启发工程呼吸道病毒诱导的心肌炎的动态功能评估。","authors":"Haote Han, Ling Zou, Jiaru Fang, Xiaobao Xu, Dongxin Xu, Xuelian Lyu, Jilin Zheng and Ning Hu*, ","doi":"10.1021/acsnano.5c07559","DOIUrl":null,"url":null,"abstract":"<p >Respiratory virus-induced myocarditis (RVIM) represents an escalating clinical challenge, attributed to rising incidence and widespread viral infections such as influenza and severe acute respiratory syndrome. This type of myocarditis is commonly associated with malignant arrhythmias and acute cardiac dysfunction, demanding the sensitive diagnostic tools to detect the functional abnormalities at their early stages. Current diagnostic strategies that rely on cardiac biomarkers and imaging modalities, often lack the temporal resolution and specificity to identify subtle myocardial alterations during the initial phases of disease. Moreover, these approaches are constrained to dynamically reflect the electrophysiological changes and fail to adequately resolve the intercellular differences at high spatial resolution. Herein, we present a multimodal biosensing platform that integrates microelectrode array (MEA) electrophysiology with calcium imaging. This platform enables simultaneous and dynamic monitoring of electrical activity and calcium transients in multiple cardiomyocytes at single-cell resolution. Using an <i>in vitro</i> model of respiratory virus-infected cardiomyocytes, we observed that exposure to SARS-CoV-2 or H1N1 pseudoviruses induced abnormal electrical activities and calcium transients, indicating the impaired excitation-contraction properties. Notably, respiratory virus-infected cardiomyocytes treated with the calcium channel blocker nifedipine effectively restore from the abnormal state. This multimodal biosensing system constitutes a robust preclinical platform to facilitate dynamic monitoring of arrhythmic activity and explore the respiratory virus-associated myocardial dysfunction at early stages. Furthermore, this multifuntional platform supports high-throughput therapeutic screening and quantitative evaluation of pharmacological responses, offering a technically versatile framework for translational investigation.</p>","PeriodicalId":21,"journal":{"name":"ACS Nano","volume":"19 31","pages":"28502–28515"},"PeriodicalIF":16.0000,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cardiomyocyte-Based Multimodal Biosensing Platform for Dynamic Functional Assessment of Bioinspired Engineered Respiratory Virus-Induced Myocarditis\",\"authors\":\"Haote Han, Ling Zou, Jiaru Fang, Xiaobao Xu, Dongxin Xu, Xuelian Lyu, Jilin Zheng and Ning Hu*, \",\"doi\":\"10.1021/acsnano.5c07559\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Respiratory virus-induced myocarditis (RVIM) represents an escalating clinical challenge, attributed to rising incidence and widespread viral infections such as influenza and severe acute respiratory syndrome. This type of myocarditis is commonly associated with malignant arrhythmias and acute cardiac dysfunction, demanding the sensitive diagnostic tools to detect the functional abnormalities at their early stages. Current diagnostic strategies that rely on cardiac biomarkers and imaging modalities, often lack the temporal resolution and specificity to identify subtle myocardial alterations during the initial phases of disease. Moreover, these approaches are constrained to dynamically reflect the electrophysiological changes and fail to adequately resolve the intercellular differences at high spatial resolution. Herein, we present a multimodal biosensing platform that integrates microelectrode array (MEA) electrophysiology with calcium imaging. This platform enables simultaneous and dynamic monitoring of electrical activity and calcium transients in multiple cardiomyocytes at single-cell resolution. Using an <i>in vitro</i> model of respiratory virus-infected cardiomyocytes, we observed that exposure to SARS-CoV-2 or H1N1 pseudoviruses induced abnormal electrical activities and calcium transients, indicating the impaired excitation-contraction properties. Notably, respiratory virus-infected cardiomyocytes treated with the calcium channel blocker nifedipine effectively restore from the abnormal state. This multimodal biosensing system constitutes a robust preclinical platform to facilitate dynamic monitoring of arrhythmic activity and explore the respiratory virus-associated myocardial dysfunction at early stages. Furthermore, this multifuntional platform supports high-throughput therapeutic screening and quantitative evaluation of pharmacological responses, offering a technically versatile framework for translational investigation.</p>\",\"PeriodicalId\":21,\"journal\":{\"name\":\"ACS Nano\",\"volume\":\"19 31\",\"pages\":\"28502–28515\"},\"PeriodicalIF\":16.0000,\"publicationDate\":\"2025-07-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Nano\",\"FirstCategoryId\":\"88\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acsnano.5c07559\",\"RegionNum\":1,\"RegionCategory\":\"材料科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Nano","FirstCategoryId":"88","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acsnano.5c07559","RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
Cardiomyocyte-Based Multimodal Biosensing Platform for Dynamic Functional Assessment of Bioinspired Engineered Respiratory Virus-Induced Myocarditis
Respiratory virus-induced myocarditis (RVIM) represents an escalating clinical challenge, attributed to rising incidence and widespread viral infections such as influenza and severe acute respiratory syndrome. This type of myocarditis is commonly associated with malignant arrhythmias and acute cardiac dysfunction, demanding the sensitive diagnostic tools to detect the functional abnormalities at their early stages. Current diagnostic strategies that rely on cardiac biomarkers and imaging modalities, often lack the temporal resolution and specificity to identify subtle myocardial alterations during the initial phases of disease. Moreover, these approaches are constrained to dynamically reflect the electrophysiological changes and fail to adequately resolve the intercellular differences at high spatial resolution. Herein, we present a multimodal biosensing platform that integrates microelectrode array (MEA) electrophysiology with calcium imaging. This platform enables simultaneous and dynamic monitoring of electrical activity and calcium transients in multiple cardiomyocytes at single-cell resolution. Using an in vitro model of respiratory virus-infected cardiomyocytes, we observed that exposure to SARS-CoV-2 or H1N1 pseudoviruses induced abnormal electrical activities and calcium transients, indicating the impaired excitation-contraction properties. Notably, respiratory virus-infected cardiomyocytes treated with the calcium channel blocker nifedipine effectively restore from the abnormal state. This multimodal biosensing system constitutes a robust preclinical platform to facilitate dynamic monitoring of arrhythmic activity and explore the respiratory virus-associated myocardial dysfunction at early stages. Furthermore, this multifuntional platform supports high-throughput therapeutic screening and quantitative evaluation of pharmacological responses, offering a technically versatile framework for translational investigation.
期刊介绍:
ACS Nano, published monthly, serves as an international forum for comprehensive articles on nanoscience and nanotechnology research at the intersections of chemistry, biology, materials science, physics, and engineering. The journal fosters communication among scientists in these communities, facilitating collaboration, new research opportunities, and advancements through discoveries. ACS Nano covers synthesis, assembly, characterization, theory, and simulation of nanostructures, nanobiotechnology, nanofabrication, methods and tools for nanoscience and nanotechnology, and self- and directed-assembly. Alongside original research articles, it offers thorough reviews, perspectives on cutting-edge research, and discussions envisioning the future of nanoscience and nanotechnology.